Medical chief exercises $2.48 options and sells 5,000 shares at Enliven Therapeutics (ELVN).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Helen Louise Collins, Chief Medical Officer of Enliven Therapeutics (ELVN), exercised options for 5,000 shares at $2.48 per share and simultaneously sold those shares at a weighted average price of $38.4684 per share on October 19, 2026. This transaction was conducted under a Rule 10b5-1 trading plan adopted on October 19, 2025.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.